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Background:  Mesenchymal stem cells (MSCs) are ideal for “off-the-shelf” therapy for myocardial infarction (MI). Systemic and local myocardial 
cell delivery methods are being evaluated, but the best method to enhance cell retention is unknown. 18F-fluorodeoxyglucose (FDG) labeled MSCs 
have been proposed to measure acute cell retention; however, little is known on labeling efficiency and how labeling affects cell viability.
Methods:  5-15 million cells were incubated with 10-15 mCi of FDG at 37 degrees for 1 hour with intermittent mixing followed by 2 washes. 
Labeling efficiency was defined as radioactivity in the pellet after 2 washes divided by the total radioactivity of all the supernatant collected. Effects 
of insulin on FDG uptake and effects of FDG on cell viability (trypan blue) were evaluated. Intramyocardial injection of MSCs was done in a swine MI 
model using a transendocardial injection catheter. Injection was guided using a custom X-ray/MRI fusion interventional guidance system followed by 
PET-CT scan (figure).
Results:  Labeling efficiency ranged from 4-8%. There was no change in cell viability post labeling. Insulin had no effect on FDG uptake by MSCs. 
Number of cells and initial FDG activity were the greatest factors affecting labeling efficiency. Acute cell retention following intramyocardial injection 
was 64% at 1 hour.
Conclusions:  Labeling MSCs with FDG is feasible and does not influence cell viability. Intramyocardial injection and quantification of FDG labeled 
MSCs is feasible.
 
